Literature DB >> 21730189

T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications.

Frederic Lluis1, Luigi Ombrato, Elisa Pedone, Stefano Pepe, Bradley J Merrill, Maria Pia Cosma.   

Abstract

The heterochromatin barrier must be overcome to generate induced pluripotent stem cells and cell fusion-mediated reprogrammed hybrids. Here, we show that the absence of T-cell factor 3 (Tcf3), a repressor of β-catenin target genes, strikingly and rapidly enhances the efficiency of neural precursor cell (NPC) reprogramming. Remarkably, Tcf3(-/-) ES cells showed a genome-wide increase in AcH3 and decrease in H3K9me3 and can reprogram NPCs after fusion greatly. In addition, during reprogramming of NPCs into induced pluripotent stem cells, the silencing of Tcf3 increased AcH3 and decreased the number of H3K9me3-positive heterochromatin foci early and long before reactivation of the endogenous stem cell genes. In conclusion, our data suggest that Tcf3 functions as a repressor of the reprogramming potential of somatic cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730189      PMCID: PMC3142002          DOI: 10.1073/pnas.1017402108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin.

Authors:  B J Merrill; U Gat; R DasGupta; E Fuchs
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

2.  Tcf3: a transcriptional regulator of axis induction in the early embryo.

Authors:  Bradley J Merrill; H Amalia Pasolli; Lisa Polak; Michael Rendl; Maria J García-García; Kathryn V Anderson; Elaine Fuchs
Journal:  Development       Date:  2003-12-10       Impact factor: 6.868

3.  Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.

Authors:  Nishant Singhal; Johannes Graumann; Guangming Wu; Marcos J Araúzo-Bravo; Dong Wook Han; Boris Greber; Luca Gentile; Matthias Mann; Hans R Schöler
Journal:  Cell       Date:  2010-06-11       Impact factor: 41.582

4.  Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.

Authors:  Hiroki Hikasa; Sergei Y Sokol
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

5.  Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells.

Authors:  M Tada; Y Takahama; K Abe; N Nakatsuji; T Tada
Journal:  Curr Biol       Date:  2001-10-02       Impact factor: 10.834

6.  Reprogramming towards pluripotency requires AID-dependent DNA demethylation.

Authors:  Nidhi Bhutani; Jennifer J Brady; Mara Damian; Alessandra Sacco; Stéphane Y Corbel; Helen M Blau
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

7.  β-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism.

Authors:  Kevin F Kelly; Deborah Y Ng; Gowtham Jayakumaran; Geoffrey A Wood; Hiroshi Koide; Bradley W Doble
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

8.  Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification.

Authors:  Hiroki Hikasa; Jerome Ezan; Keiji Itoh; Xiaotong Li; Michael W Klymkowsky; Sergei Y Sokol
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

9.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.

Authors:  Noboru Sato; Laurent Meijer; Leandros Skaltsounis; Paul Greengard; Ali H Brivanlou
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

10.  The Wnt/β-catenin signaling pathway tips the balance between apoptosis and reprograming of cell fusion hybrids.

Authors:  Frederic Lluis; Elisa Pedone; Stefano Pepe; Maria Pia Cosma
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

View more
  27 in total

Review 1.  Chromatin changes in reprogramming of mammalian somatic cells.

Authors:  Rong Xu; Shiqiang Zhang; Anmin Lei
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

Review 2.  Maintaining embryonic stem cell pluripotency with Wnt signaling.

Authors:  Sergei Y Sokol
Journal:  Development       Date:  2011-09-08       Impact factor: 6.868

Review 3.  Resetting epigenetic signatures to induce somatic cell reprogramming.

Authors:  Frederic Lluis; Maria Pia Cosma
Journal:  Cell Mol Life Sci       Date:  2012-08-30       Impact factor: 9.261

Review 4.  The cellular memory disc of reprogrammed cells.

Authors:  Seyed Hadi Anjamrooz
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

Review 5.  TCF/LEFs and Wnt signaling in the nucleus.

Authors:  Ken M Cadigan; Marian L Waterman
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

6.  The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State.

Authors:  Karthik Arumugam; William Shin; Valentina Schiavone; Lukas Vlahos; Xiaochuan Tu; Davide Carnevali; Jordan Kesner; Evan O Paull; Neus Romo; Prem Subramaniam; Jeremy Worley; Xiangtian Tan; Andrea Califano; Maria Pia Cosma
Journal:  Cell Rep       Date:  2020-12-08       Impact factor: 9.423

7.  Stage-specific regulation of reprogramming to induced pluripotent stem cells by Wnt signaling and T cell factor proteins.

Authors:  Ritchie Ho; Bernadett Papp; Jackson A Hoffman; Bradley J Merrill; Kathrin Plath
Journal:  Cell Rep       Date:  2013-06-20       Impact factor: 9.423

Review 8.  Progress in the reprogramming of somatic cells.

Authors:  Tianhua Ma; Min Xie; Timothy Laurent; Sheng Ding
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

Review 9.  Signaling pathways in induced naïve pluripotency.

Authors:  Shoudong Ye; Dahai Liu; Qi-Long Ying
Journal:  Curr Opin Genet Dev       Date:  2014-08-28       Impact factor: 5.578

10.  Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors.

Authors:  Daniela Sanges; Giacoma Simonte; Umberto Di Vicino; Neus Romo; Isabel Pinilla; Marta Nicolás; Maria Pia Cosma
Journal:  J Clin Invest       Date:  2016-07-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.